Boston Partners Sells 772 Shares of The Chemours Company (NYSE:CC)

Boston Partners lessened its stake in The Chemours Company (NYSE:CC – Get Rating) by 2.8% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 26,663 shares of the specialty chemicals company’s stock after selling 772 shares during the period. Boston Partners’ holdings in Chemours were worth $657,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently modified their holdings of CC. TCI Wealth Advisors Inc. increased its holdings in Chemours by 19.7% during the 3rd quarter. TCI Wealth Advisors Inc. now owns 2,179 shares of the specialty chemicals company’s stock valued at $54,000 after purchasing an additional 358 shares during the period. IFP Advisors Inc increased its holdings in Chemours by 9.0% during the 3rd quarter. IFP Advisors Inc now owns 4,610 shares of the specialty chemicals company’s stock valued at $60,000 after purchasing an additional 382 shares during the period. Jeppson Wealth Management LLC increased its holdings in Chemours by 3.7% during the 3rd quarter. Jeppson Wealth Management LLC now owns 11,099 shares of the specialty chemicals company’s stock valued at $274,000 after purchasing an additional 400 shares during the period. Baird Financial Group Inc. increased its holdings in Chemours by 4.3% during the 1st quarter. Baird Financial Group Inc. now owns 10,390 shares of the specialty chemicals company’s stock valued at $327,000 after purchasing an additional 426 shares during the period. Finally, National Bank of Canada FI increased its holdings in Chemours by 0.5% during the 2nd quarter. National Bank of Canada FI now owns 100,194 shares of the specialty chemicals company’s stock valued at $3,213,000 after purchasing an additional 475 shares during the period. Institutional investors own 71.89% of the company’s stock.

Get Chemours alerts:

Chemours Stock Performance

Chemours stock opened at $34.67 on Wednesday. The company has a quick ratio of 0.96, a current ratio of 1.70 and a debt-to-equity ratio of 3.24. The company has a market capitalization of $5.23 billion, a P/E ratio of 9.71, a PEG ratio of 0.71 and a beta of 1.88. The stock’s 50 day moving average is $32.65 and its 200 day moving average is $31.90. The Chemours Company has a twelve month low of $22.56 and a twelve month high of $44.95.

Chemours Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Wednesday, March 15th. Investors of record on Friday, February 24th will be paid a $0.25 dividend. The ex-dividend date is Thursday, February 23rd. This represents a $1.00 annualized dividend and a dividend yield of 2.88%. Chemours’s payout ratio is currently 28.01%.

Analysts Set New Price Targets

CC has been the topic of a number of research analyst reports. StockNews.com downgraded Chemours from a “buy” rating to a “hold” rating in a report on Monday. Bank of America upgraded Chemours from a “neutral” rating to a “buy” rating and boosted their price target for the company from $37.00 to $40.00 in a report on Wednesday, January 11th. Royal Bank of Canada upped their target price on Chemours from $33.00 to $36.00 and gave the stock a “sector perform” rating in a report on Monday. The Goldman Sachs Group upped their target price on Chemours from $34.00 to $38.00 and gave the stock a “neutral” rating in a report on Tuesday. Finally, Citigroup upped their target price on Chemours from $33.00 to $35.00 and gave the stock a “neutral” rating in a report on Monday. One investment analyst has rated the stock with a sell rating, seven have given a hold rating and three have issued a buy rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Hold” and an average price target of $36.33.

About Chemours

(Get Rating)

The Chemours Co is a holding company, which engages in the provision of performance chemicals. The firm delivers solutions, which include a range of industrial and chemical products for markets including coatings, plastics, refrigeration and air conditioning, transportation, semiconductor and consumer electronics, and general industrial.

Featured Stories

• Get a free copy of the StockNews.com research report on Chemours (CC)
• LCI Industries Diversification Strategy Pays Off
• Is It Time To Buy The Dip In The Coca-Cola Company 
• Ex-Dividend Date vs. Record Date: What’s the Difference?
• How Does the Consumer Price Index Affect the Stock Market?
• Are Denny’s Corporation Investors Due For A Grand Slam?

Receive News & Ratings for Chemours Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemours and related companies with MarketBeat.com's FREE daily email newsletter.